Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cipla
Express Scripts
Julphar
US Army
US Department of Justice

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 9,629,799

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,629,799
Title:Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
Inventor(s): Imran; Mir (Los Altos Hills, CA)
Assignee: Rani Therapeutics, LLC (San Jose, CA)
Application Number:13/538,903
Patent Claims:see list of patent claims

Details for Patent 9,629,799

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23 ➤ Sign Up Rani Therapeutics, LLC (San Jose, CA) 2030-12-23 RX Orphan search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Sign Up Rani Therapeutics, LLC (San Jose, CA) 2030-12-23 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07 ➤ Sign Up Rani Therapeutics, LLC (San Jose, CA) 2030-12-23 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07 ➤ Sign Up Rani Therapeutics, LLC (San Jose, CA) 2030-12-23 RX search
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14 ➤ Sign Up Rani Therapeutics, LLC (San Jose, CA) 2030-12-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
UBS
Argus Health
Cipla
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.